Apple has made a new bet on augmented reality (AR), buying Akonia Holographics, which makes lenses for the technology. The secretive deal, confirmed last week, comes amid other augmented reality moves by the likes of PayPal and Target. Apple bought the Colorado-based company for an undisclosed sum.
“Apple buys smaller companies from time to time, and we generally don’t discuss our purpose or plans,” Apple told Reuters, declining to release more details.
Akonia’s HoloMirror technology enables “headsets that are thin, transparent and light-weight, while achieving high [field of view (FOV)] with low manufacturing cost,” Akonia stated on its website. It holds 140 patents associated with “holographic systems and materials,” and employs many of the people behind those inventions. The company claims that its “thin, transparent smart glass lenses … display vibrant, full-color, wide field of view images.”
The company launched in 2012 and focused on storing holographic data before shifting to glasses that can be used for augmented reality.
Augmented reality glasses enable users to see digital information in additional to real world visuals. In a retail setting, that would mean virtual information appearing over real products in stores.
Full Content: PYMNTS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan